Huaheng Co., Ltd. (837995): The company plans to invest externally to establish a wholly-owned subsidiary, Jiujiang Boen Biotechnology Co., Ltd.

NightAirdropper · 2026-03-10T22:35:08+00:00

Huaheng Co., Ltd. announced the establishment of a wholly-owned subsidiary, Jiujiang Boen Biotechnology Co., Ltd., with a registered capital of 5 million yuan, aimed at expanding the domestic market. The investment plan has been approved by the board of directors and requires approval from the shareholders' meeting.

NightAirdropper

2026-03-10 22:35:08

Abstract generation in progress

Meiri News, Huaheng Co., Ltd. announced on March 9 that to meet the company’s business development needs, reasonably plan strategic layout, and expand the domestic market, the company intends to establish a wholly owned subsidiary through external investment: Jiujiang Bo’en Biotechnology Co., Ltd., registered in Ruichang City, Jiangxi Province, with a registered capital of 5 million yuan. The company will invest 5 million yuan, holding 100% of the shares. The specific registration information is subject to approval and registration by the relevant local authorities. On March 9, 2026, the company held the fourth meeting of the fourth board of directors, which approved the proposal regarding the company’s plan to establish a wholly owned subsidiary through external investment. According to the company’s articles of association and the “External Investment Management System,” this external investment still requires approval by the company’s shareholders’ meeting.

(Reporter Zeng Jianhui)

Disclaimer: The content and data of this article are for reference only and do not constitute investment advice. Please verify before use. Proceed at your own risk.

Daily Economic News

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.